Enzymology in Drug Discovery

Enzymes are the macromolecular and micromolecular proteins in the drug design that act as drug targets for the diseases in the process of discovery of drugs as well as its development. There are a number of drug targets which are involved in the designing of the drugs. Drug target is a nucleic acid or a protein whose activity can be modified by a drug itself. The drug can be a chemical compound with a small molecular weight or a biological compound, such as an antibody or a recombinant protein. The drug target should be effective in the disease by relevant in vitro or in vivo models and analysis.

  • Drug designing using enzymes
  • Drug development using enzymes
  • Drug modelling
  • Drug targeting

Related Conference of Enzymology in Drug Discovery

August 15-16, 2018

16th Asia Pacific Biotechnology Congress

Singapore
August 27-28, 2018

5th International Conference on Glycobiology & Glycoproteomics

Toronto, Ontario, Canada
August 27-28, 2018

3rd International Conference on Molecular Biology & Nucleic Acids

Toronto, Ontario, Canada
September 17-19, 2018

4th Glycobiology World Congress

Rome, Italy
September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018

4th International Conference on Biochemistry & Metabolomics

Los Angeles, California, USA
October 18-19, 2018

10th International Congress on Structural Biology

Helsinki, Finland
November 19-20, 2018

15th World Congress on

Structural Biology

Lisbon, Portugal
February 28-March 01, 2019

5th International Conference on Enzymology and Molecular Biology

Berlin, Germany

22nd Global Congress on Biotechnology

February 28-March 02, 2019 Berlin, Germany

Enzymology in Drug Discovery Conference Speakers

Recommended Sessions

Related Journals

Are you interested in